174 related articles for article (PubMed ID: 24880663)
21. Major histocompatibility complex class I and class II alleles may confer susceptibility to or protection against morphea: findings from the Morphea in Adults and Children cohort.
Jacobe H; Ahn C; Arnett FC; Reveille JD
Arthritis Rheumatol; 2014 Nov; 66(11):3170-7. PubMed ID: 25223600
[TBL] [Abstract][Full Text] [Related]
22. Changes in Disease Activity and Damage Over Time in Patients With Morphea.
O'Brien JC; Nymeyer H; Green A; Jacobe HT
JAMA Dermatol; 2020 May; 156(5):513-520. PubMed ID: 32236501
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of skin thickness lesions in patients with Lyme disease measured by modified Rodnan total skin score.
Moniuszko A; Gińdzieńska-Sieśkiewicz E; Pancewicz SA; Czupryna P; Zajkowska J; Sierakowski S
Rheumatol Int; 2012 Oct; 32(10):3189-91. PubMed ID: 21960047
[TBL] [Abstract][Full Text] [Related]
24. Effects of UVA1 Phototherapy on Expression of Human Endogenous Retroviral Sequence (HERV)-K10 gag in Morphea: A Preliminary Study.
Kowalczyk MJ; Teresiak-Mikołajczak E; Dańczak-Pazdrowska A; Żaba R; Adamski Z; Osmola-Mańkowska A
Med Sci Monit; 2017 Jan; 23():505-512. PubMed ID: 28130554
[TBL] [Abstract][Full Text] [Related]
25. Morphea: a practical review of its diagnosis, classification and treatment.
Rodríguez-Salgado P; García-Romero MT
Gac Med Mex; 2019; 155(5):483-491. PubMed ID: 32091025
[TBL] [Abstract][Full Text] [Related]
26. New developments in localized scleroderma.
Zulian F
Curr Opin Rheumatol; 2008 Sep; 20(5):601-7. PubMed ID: 18698185
[TBL] [Abstract][Full Text] [Related]
27. Morphea disease activity during pregnancy: A case series.
Walker AM; Bermas BL; Jacobe HT
J Dermatol; 2022 Dec; 49(12):1278-1283. PubMed ID: 36093764
[TBL] [Abstract][Full Text] [Related]
28. Psychological distress in patients with morphea and eosinophilic fasciitis.
Kroft EB; de Jong EM; Evers AW
Arch Dermatol; 2009 Sep; 145(9):1017-22. PubMed ID: 19770441
[TBL] [Abstract][Full Text] [Related]
29. Development and Validation of the Morphea Activity Measure in Patients With Pediatric Morphea.
García-Romero MT; Tollefson M; Pope E; Brandling-Bennett HA; Paller AS; Keimig E; Arkin L; Wanat KA; Humphrey SR; Werth VP; Oza V; Jacobe H; Fett N; Cordoro KM; Medina-Vera I; Chiu YE
JAMA Dermatol; 2023 Mar; 159(3):299-307. PubMed ID: 36753150
[TBL] [Abstract][Full Text] [Related]
30. Activity assessment in morphea using color Doppler ultrasound.
Wortsman X; Wortsman J; Sazunic I; Carreño L
J Am Acad Dermatol; 2011 Nov; 65(5):942-8. PubMed ID: 21550692
[TBL] [Abstract][Full Text] [Related]
31. Keloid morphea and nodular scleroderma: two distinct clinical variants of scleroderma?
Rencic A; Brinster N; Nousari CH
J Cutan Med Surg; 2003; 7(1):20-4. PubMed ID: 12362259
[TBL] [Abstract][Full Text] [Related]
32. DLQI-R scoring improves the discriminatory power of the Dermatology Life Quality Index in patients with psoriasis, pemphigus and morphea.
Rencz F; Gulácsi L; Péntek M; Szegedi A; Remenyik É; Bata-Csörgő Z; Bali G; Hidvégi B; Tamási B; Poór AK; Hajdu K; Holló P; Kinyó Á; Sárdy M; Brodszky V
Br J Dermatol; 2020 May; 182(5):1167-1175. PubMed ID: 31419310
[TBL] [Abstract][Full Text] [Related]
33. Localized scleroderma: a series of 52 patients.
Toledano C; Rabhi S; Kettaneh A; Fabre B; Fardet L; Tiev KP; Cabane J
Eur J Intern Med; 2009 May; 20(3):331-6. PubMed ID: 19393504
[TBL] [Abstract][Full Text] [Related]
34. Inflammatory arthritis in pediatric patients with morphea.
Kashem SW; Correll CK; Vehe RK; Hobday PM; Binstadt BA; Maguiness SM
J Am Acad Dermatol; 2018 Jul; 79(1):47-51.e2. PubMed ID: 29535035
[TBL] [Abstract][Full Text] [Related]
35. Unilateral multisegmental morphea.
Fleming KF; Wu JJ; Dyson SW; Tsuchiya AM
Cutis; 2011 Jul; 88(1):41-2. PubMed ID: 21877506
[TBL] [Abstract][Full Text] [Related]
36. Color Doppler Ultrasound Assessment of Subclinical Activity With Scoring of Morphea.
Parra-Cares J; Wortsman X; Alfaro-Sepúlveda D; Mellado-Francisco G; Ramírez-Cornejo C; Vera-Kellet C
J Cutan Med Surg; 2023; 27(5):454-460. PubMed ID: 37533149
[TBL] [Abstract][Full Text] [Related]
37. Long-standing morphea and the risk of squamous cell carcinoma of the skin.
Heck J; Olk J; Kneitz H; Hamm H; Goebeler M
J Dtsch Dermatol Ges; 2020 Jul; 18(7):669-673. PubMed ID: 32364667
[TBL] [Abstract][Full Text] [Related]
38. Effects of low dose ultraviolet A-1 phototherapy on morphea.
Gruss CJ; Von Kobyletzki G; Behrens-Williams SC; Lininger J; Reuther T; Kerscher M; Altmeyer P
Photodermatol Photoimmunol Photomed; 2001 Aug; 17(4):149-55. PubMed ID: 11499534
[TBL] [Abstract][Full Text] [Related]
39. Patients with morphea with neurologic involvement: A cross-sectional study and review from the morphea in adults and children cohort.
Abbas LF; Joseph AK; Zhu JL; Okuda D; Jacobe HT
J Am Acad Dermatol; 2023 Jan; 88(1):172-174. PubMed ID: 34998956
[No Abstract] [Full Text] [Related]
40. Clinical, Histologic, and Transcriptomic Evaluation of Sequential Fat Grafting for Morphea: A Nonrandomized Controlled Trial.
Liu J; Wang J; Zhang Q; Lu F; Cai J
JAMA Dermatol; 2024 Apr; 160(4):425-433. PubMed ID: 38324287
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
